Technology News and Research

RSS

Australian project aims to improve the early detection of breast cancer

The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.

4 Oct 2011

X-BODY, TRL enter collaboration to identify therapeutic target epitopes

X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.

4 Oct 2011

New research relates role of gender and weight management in overall sleep patterns

The benefits of a good night's sleep to overall health have long been reported. Now, new research has emerged relating to the role gender and weight management play in overall sleep patterns. The abstract, Gender Differences in a Naturalistic Observational Study of Sleep and BMI, was presented during a poster session at the annual Obesity Society meeting in Orlando, Florida this week.

4 Oct 2011

FDA grants 510(k) clearance to Carticept Medical's Navigator Delivery System

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has received 510(k) clearance from the Food and Drug Administration to market its Navigator™ Delivery System (Navigator DS) in the United States.

4 Oct 2011

NCI's Center for Cancer Research awards $37 million recompete contract to Harris

Harris Corporation, an international communications and information technology company, has been awarded a $37 million recompete contract by the National Cancer Institute's Center for Cancer Research.

4 Oct 2011

Sequenom launches iPLEX ADME PGx panel to genotype polymorphisms

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced the launch of its iPLEX ADME PGx panel developed to genotype polymorphisms in genes associated with drug absorption, distribution, metabolism, and excretion (ADME).

4 Oct 2011

CRT, Cancer Research UK establish group of scientists with expertise in lipid metabolism

Cancer Research Technology, Cancer Research UK's commercial arm, has established a group of scientists with expertise in lipid metabolism - getting energy from fats and making building blocks for cell growth - to develop targets for potential new cancer drugs.

4 Oct 2011

Life Technologies, CHEO researcher partner to co-develop microbial detection tests

The Children's Hospital of Eastern Ontario (CHEO) Research Institute is pleased to announce that one of its principal investigators in infectious disease has signed a contract with Life Technologies, an internationally renowned biotech tools company headquartered in Carlsbad, California, to share information that will help to develop tests that uniquely amplify and detect the DNA coding for infectious diseases.

4 Oct 2011

Lipomannan on TB bacterium's outer cell surface can block TNF production

The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts to remain hidden from the human immune system.

4 Oct 2011

Phagenesis closes Series B funding

Phagenesis Ltd, the global leader in the treatment of dysphagia (inability to swallow safely) today announced that it has closed a €7 million Series B funding round designed to accelerate the company's development plans.

4 Oct 2011

Telestroke improves care and reduces costs

The use of long-distance video and data hookups to link remote community hospitals with stroke neurologists in large centres provides the same level of care as having everyone in the same room, according to a new study presented today at the Canadian Stroke Congress.

4 Oct 2011

G&D, Precise Biometrics partner to provide Match-on-Card technology

Precise Biometrics announces that they have entered into a partnership agreement with Giesecke & Devrient (G&D) that will provide Precise Match-on-Card technology for use on G&D smart-cards.

4 Oct 2011

Creabilis receives $20 million in Series B funding

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, inflammation and pain, has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures.

4 Oct 2011

Complete Genomics, Scripps collaborate to unlock genetic secrets of lifelong health

Complete Genomics Inc., the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health.

4 Oct 2011

Cancer patients prefer to use Web-based technology for quality of life survey

When cancer patients are given the choice, they are significantly more likely to use Web-based technology to answer questions about their quality of life six months after treatment, compared to a paper survey, according to a unique study presented at a scientific session, October 5, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

4 Oct 2011

TAU researcher implants robotic cerebellum to repair motor function

With new cutting-edge technology aimed at providing amputees with robotic limbs, a Tel Aviv University researcher has successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, restoring its capacity for movement.

4 Oct 2011

TriLogic, Mission Pharmacal partner to develop new drug delivery system

Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.

4 Oct 2011

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.

3 Oct 2011

IMRIS unveils VISIUS Surgical Theatre

IMRIS Inc. today officially launched VISIUS Surgical Theatre, its new global product branding at the Congress of Neurological Surgeons (CNS) being held in Washington DC.

3 Oct 2011

USAID awards ICF International $21.5M contract for LEAD program

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has won a new contract with the U.S. Agency for International Development (USAID) Regional Development Mission for Asia to support the Low Emissions Asian Development (LEAD) program. The contract has a value of $21.5 million and a term of five years.

3 Oct 2011